Abstract: The present invention relates to novel crystalline forms of 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-N-hydroxyethyl-imidazo[1,2-a]pyridine-6-carboxamide mesylate salt and to mixture thereof. Further, the present invention also relates to processes for obtaining them, the use of said compounds for the treatment of gastrointestinal disorders, and pharmaceutical compositions containing them.
Type:
Application
Filed:
December 16, 2004
Publication date:
May 17, 2007
Applicant:
TRAZENECA AB
Inventors:
Lars Lilljequist, Maria Lindkvist, Peter Nordberg, Ursula Pettersson, Tesfai Sebhatu